Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder
暂无分享,去创建一个
D. Han | Young Sik Lee | G. Bahn | S. Bhang | S. Lee | Subin Park | J. Hong | H. Yoo | Y. Joung | Eui-Jung Kim | Minha Hong | Bongseog Kim | Seung Yup Lee
[1] M. Weiser,et al. Functioning of Young Adults With ADHD in the Military , 2019, Journal of attention disorders.
[2] D. Han,et al. Clinical Utility and Cut-Off Scores of the Korean Adult Attention-Deficit/Hyperactivity Disorder Rating Scale , 2019, Soa--ch'ongsonyon chongsin uihak = Journal of child & adolescent psychiatry.
[3] D. Han,et al. Comparison of Attention-Deficit/Hyperactivity Disorder Practice in Adults According to a Training Background in Child Psychiatry , 2019, Soa--ch'ongsonyon chongsin uihak = Journal of child & adolescent psychiatry.
[4] Ivanei E. Bramati,et al. Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples. , 2019, The American journal of psychiatry.
[5] H. Yoo,et al. Developmental Trajectories of Attention in Normal Korean Population , 2019, Soa--ch'ongsonyon chongsin uihak = Journal of child & adolescent psychiatry.
[6] G. Bahn,et al. Social function of adult men with attention-deficit/hyperactivity disorder in the context of military service , 2018, Neuropsychiatric disease and treatment.
[7] E Sobanski,et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD , 2018, European Psychiatry.
[8] B. Franke,et al. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan , 2018, European Neuropsychopharmacology.
[9] I. Hwang,et al. Genetic associations between ADHD and dopaminergic genes (DAT1 and DRD4) VNTRs in Korean children , 2018, Genes & Genomics.
[10] F. Castellanos,et al. Predicting the Adult Functional Outcomes of Boys With ADHD 33 Years Later. , 2018, Journal of the American Academy of Child and Adolescent Psychiatry.
[11] A. Koyanagi,et al. Attention‐deficit/hyperactivity disorder symptoms and suicidal behavior in adult psychiatric outpatients , 2018, Psychiatry and clinical neurosciences.
[12] P. Asherson,et al. Emotion dysregulation in attention-deficit/hyperactivity disorder and borderline personality disorder , 2018, Borderline Personality Disorder and Emotion Dysregulation.
[13] M. O’Donovan,et al. Investigating late‐onset ADHD: a population cohort investigation , 2018, Journal of child psychology and psychiatry, and allied disciplines.
[14] M. Pompili,et al. Suicide risk in attention-deficit/hyperactivity disorder. , 2018, Psychiatria Danubina.
[15] Soon-Ah Chang,et al. Clinical Utility of the Korean Version of the WHO Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale Screener , 2018, Psychiatry investigation.
[16] F. Reimherr,et al. ADHD and Anxiety: Clinical Significance and Treatment Implications , 2017, Current Psychiatry Reports.
[17] Bung-Nyun Kim,et al. Interaction between DRD2 and lead exposure on the cortical thickness of the frontal lobe in youth with attention-deficit/hyperactivity disorder , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[18] M. Liebrenz,et al. Skills and compensation strategies in adult ADHD – A qualitative study , 2017, PloS one.
[19] P. Chokka,et al. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach , 2017, BMC Psychiatry.
[20] Z. Lv,et al. The association between attention deficit/hyperactivity disorder and internet addiction: a systematic review and meta-analysis , 2017, BMC Psychiatry.
[21] Elizabeth B. Owens,et al. Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity , 2017, Journal of child psychology and psychiatry, and allied disciplines.
[22] Cynthia Rudin,et al. The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5 , 2017, JAMA psychiatry.
[23] Maria Panagiotidi,et al. Problematic Video Game Play and ADHD Traits in an Adult Population , 2017, Cyberpsychology Behav. Soc. Netw..
[24] D. Galland,et al. Implications du trouble déficitaire de l’attention en psychiatrie légale : revue de littérature systématique , 2017 .
[25] Alan M. Zaslavsky,et al. The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys , 2017, ADHD Attention Deficit and Hyperactivity Disorders.
[26] H. Holling,et al. Long-Term Memory Performance in Adult ADHD , 2017, Journal of attention disorders.
[27] L. Weyandt,et al. Neuropsychological Functioning in College Students With and Without ADHD , 2017, Neuropsychology.
[28] L. Thorell,et al. Neuropsychological Functioning in Adults With ADHD and Adults With Other Psychiatric Disorders , 2017, Journal of attention disorders.
[29] Jun Won Kim,et al. The Guideline of Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder: Developed by ADHD Translational Research Center , 2016 .
[30] F. Serre,et al. Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions , 2016, Psychiatry Research.
[31] P. Lichtenstein,et al. Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study , 2016, Biological Psychiatry.
[32] V. Balanzá-Martínez,et al. Psychiatric Comorbidity at the Time of Diagnosis in Adults With ADHD , 2016, Journal of attention disorders.
[33] John T. Mitchell,et al. Method of adult diagnosis influences estimated persistence of childhood ADHD: a systematic review of longitudinal studies. , 2016, The lancet. Psychiatry.
[34] R. Tannock,et al. Symptom Manifestation and Impairments in College Students With ADHD , 2016, Journal of learning disabilities.
[35] T. Moffitt,et al. Life Span Studies of ADHD—Conceptual Challenges and Predictors of Persistence and Outcome , 2016, Current Psychiatry Reports.
[36] G. Gudjonsson,et al. A randomized controlled trial reporting functional outcomes of cognitive–behavioural therapy in medication-treated adults with ADHD and comorbid psychopathology , 2016, European Archives of Psychiatry and Clinical Neuroscience.
[37] A. London,et al. Attention Deficit Hyperactivity Disorder and adult mortality. , 2016, Preventive medicine.
[38] D. Bijlenga,et al. ADHD in old age: a review of the literature and proposal for assessment and treatment , 2016, Expert review of neurotherapeutics.
[39] I. Manor,et al. New DSM-5 criteria for ADHD - Does it matter? , 2016, Comprehensive psychiatry.
[40] J. Swanson,et al. Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome. , 2016, JAMA psychiatry.
[41] A. Danese,et al. Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood. , 2016, JAMA psychiatry.
[42] Hyejung Chang,et al. The Diagnostic Distribution of Psychiatric Disorders among the Population Under 19 Years Old: Based on the National Insurance Data , 2016 .
[43] W. Retz,et al. The intraindividual impact of ADHD on the transition of adulthood to old age , 2016, European Archives of Psychiatry and Clinical Neuroscience.
[44] E. Roughead,et al. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study , 2016, British Medical Journal.
[45] 김지혜,et al. 한국어판 바클리 집행기능결핍척도의 신뢰도 및 타당도 연구 , 2016 .
[46] G. Zalsman,et al. Adult ADHD: A new disease? , 2016, International journal of psychiatry in clinical practice.
[47] R. Stieglitz,et al. Emotional symptoms and their contribution to functional impairment in adults with attention-deficit/hyperactivity disorder , 2016, ADHD Attention Deficit and Hyperactivity Disorders.
[48] Joel L. Young,et al. Supplementary guanfacine hydrochloride as a treatment of attention deficit hyperactivity disorder in adults: A double blind, placebo-controlled study , 2016, Psychiatry Research.
[49] K. Jørgensen,et al. Cognitive behavioural therapy for ADHD in adults: systematic review and meta-analyses , 2016, ADHD Attention Deficit and Hyperactivity Disorders.
[50] D. Han,et al. Development of Korean Adult ADHD Rating Scale , 2015 .
[51] M. Abdel-Hamid,et al. Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. , 2015, JAMA psychiatry.
[52] A. Ludolph,et al. Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe , 2015, Clinical Drug Investigation.
[53] Jan K. Buitelaar,et al. Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: A systematic analysis of neuropsychological measurements , 2015, European Neuropsychopharmacology.
[54] R. Kuja‐Halkola,et al. Heritability of attention‐deficit hyperactivity disorder in adults , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[55] E. Viding,et al. Genetic and Environmental Influences on the Developmental Course of Attention-Deficit/Hyperactivity Disorder Symptoms From Childhood to Adolescence. , 2015, JAMA psychiatry.
[56] S. Dalsgaard,et al. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study , 2015, The Lancet.
[57] D. Belsky,et al. Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study. , 2015, The American journal of psychiatry.
[58] A. Ghanizadeh. A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorder , 2015, Nordic journal of psychiatry.
[59] J. Martínez-Raga,et al. Attention-deficit hyperactivity disorder (ADHD), substance use disorders, and criminality: a difficult problem with complex solutions , 2015, International journal of adolescent medicine and health.
[60] C. Kieling,et al. Cadherin‐13 gene is associated with hyperactive/impulsive symptoms in attention/deficit hyperactivity disorder , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[61] Young-Eun Jung,et al. Prevalence and correlates of attention-deficit hyperactivity disorder symptoms in Korean college students , 2015, Neuropsychiatric disease and treatment.
[62] H. Caci,et al. Effect of Treatment Modality on Long-Term Outcomes in Attention-Deficit/Hyperactivity Disorder: A Systematic Review , 2015, PloS one.
[63] T. Cummins,et al. The molecular genetic architecture of attention deficit hyperactivity disorder , 2015, Molecular Psychiatry.
[64] Donna B. Pincus,et al. Inattention symptoms and the diagnosis of comorbid attention-deficit/hyperactivity disorder among youth with generalized anxiety disorder. , 2014, Journal of anxiety disorders.
[65] R. Tremblay,et al. The developmental course of childhood inattention symptoms uniquely predicts educational attainment: A 16-year longitudinal study , 2014, Psychiatry Research.
[66] M. Pennick,et al. Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells , 2014, Neuropsychiatric disease and treatment.
[67] J. Ramos-Quiroga,et al. The Conners’ Adult ADHD Rating Scales—Short Self-Report and Observer Forms , 2014, Journal of attention disorders.
[68] Yun-Chul Hong,et al. Environmental Lead Exposure and Attention Deficit/Hyperactivity Disorder Symptom Domains in a Community Sample of South Korean School-Age Children , 2014, Environmental health perspectives.
[69] M. Srisurapanont,et al. Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD , 2014, Drug design, development and therapy.
[70] X. Castells,et al. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents. , 2014, The Cochrane database of systematic reviews.
[71] R. Findling,et al. Comorbidities in Adult Attention-Deficit/Hyperactivity Disorder: A Practical Guide to Diagnosis in Primary Care , 2014, Postgraduate medicine.
[72] N. Maneeton,et al. A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder , 2014, Neuropsychiatric disease and treatment.
[73] P. Lichtenstein,et al. Stimulant ADHD medication and risk for substance abuse. , 2014, Journal of child psychology and psychiatry, and allied disciplines.
[74] A. Young,et al. Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults , 2014, Current medical research and opinion.
[75] G. Salum,et al. ADHD in DSM-5: a field trial in a large, representative sample of 18- to 19-year-old adults , 2014, Psychological Medicine.
[76] A. Sjölander,et al. Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study , 2014, BMJ : British Medical Journal.
[77] Bung-Nyun Kim,et al. Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD) , 2014, Behavioral and Brain Functions.
[78] D. Coghill,et al. A Systematic Review of the Safety of Lisdexamfetamine Dimesylate , 2014, CNS Drugs.
[79] J. Ramos-Quiroga,et al. Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults , 2014, Expert review of neurotherapeutics.
[80] A. Philipsen,et al. Common ground in Attention Deficit Hyperactivity Disorder (ADHD) and Borderline Personality Disorder (BPD)–review of recent findings , 2014, Borderline Personality Disorder and Emotion Dysregulation.
[81] A. Sjölander,et al. Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. , 2014, JAMA psychiatry.
[82] Ellen Leibenluft,et al. Emotion dysregulation in attention deficit hyperactivity disorder. , 2014, The American journal of psychiatry.
[83] D. Nutt,et al. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology , 2014, Journal of psychopharmacology.
[84] M. Bayés,et al. Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder. , 2014, Journal of psychiatric research.
[85] L. Adler,et al. A 9-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD , 2014, Journal of attention disorders.
[86] J. Swanson,et al. Clinical practice: Adult attention deficit-hyperactivity disorder. , 2013, The New England journal of medicine.
[87] T. Banaschewski,et al. Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies , 2013, BMC Psychiatry.
[88] R. Cunill,et al. Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta‐analysis and meta‐regression , 2013, Pharmacoepidemiology and drug safety.
[89] L. Adler,et al. Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study. , 2013, The Journal of clinical psychiatry.
[90] J. Ramos-Quiroga,et al. Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines , 2013, Current medical research and opinion.
[91] K. Lesch,et al. Dances with black widow spiders: Dysregulation of glutamate signalling enters centre stage in ADHD , 2013, European Neuropsychopharmacology.
[92] D. McManus,et al. Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults , 2013, European Neuropsychopharmacology.
[93] R. Robison,et al. Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale. , 2013, Psychological assessment.
[94] P. Asherson,et al. Emotional lability, comorbidity and impairment in adults with attention-deficit hyperactivity disorder. , 2013, Journal of affective disorders.
[95] P. Hodgkins,et al. Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis , 2013, Journal of medical economics.
[96] Anthony Liu,et al. Medication for attention deficit-hyperactivity disorder and criminality. , 2013, The New England journal of medicine.
[97] S. Faraone,et al. Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study , 2013, ADHD Attention Deficit and Hyperactivity Disorders.
[98] Ji-Hae Kim,et al. The WHO Adult ADHD Self-Report Scale: Reliability and Validity of the Korean Version , 2013, Psychiatry investigation.
[99] J. Brook,et al. Adolescent ADHD and Adult Physical and Mental Health, Work Performance, and Financial Stress , 2013, Pediatrics.
[100] A. Sjölander,et al. Medication for attention deficit-hyperactivity disorder and criminality. , 2012, The New England journal of medicine.
[101] A. Philipsen. Psychotherapy in adult attention deficit hyperactivity disorder: implications for treatment and research , 2012, Expert review of neurotherapeutics.
[102] H. Nordahl,et al. Functional Impairment and Occupational Outcome in Adults With ADHD , 2012, Journal of attention disorders.
[103] R. Stieglitz,et al. Emotional dysregulation in adult ADHD: what is the empirical evidence? , 2012, Expert review of neurotherapeutics.
[104] P. Lichtenstein,et al. Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: a large Swedish population-based study of twins , 2012, Psychological Medicine.
[105] L. Hechtman,et al. Cognitive Behavior Therapy for Adults with Attention-Deficit/Hyperactivity Disorder: A Review of Recent Randomized Controlled Trials , 2012, Current Psychiatry Reports.
[106] A. Thapar,et al. Practitioner Review: What have we learnt about the causes of ADHD? , 2013, Journal of Child Psychology and Psychiatry, and Allied Disciplines.
[107] J. Ramos-Quiroga,et al. The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents , 2012, International Archives of Occupational and Environmental Health.
[108] Arthur N Westover,et al. Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review , 2012, BMC Cardiovascular Disorders.
[109] U. Müller,et al. Systematic review of national and international guidelines on attention-deficit hyperactivity disorder , 2012, Journal of psychopharmacology.
[110] B. Cha,et al. Effect of Symptoms of Adult Attention Deficit Hyperactivity Disorder on Symptoms of Post Traumatic Stress Disorder in Korean Conscripts , 2012, Psychiatry investigation.
[111] Rosemary Tannock,et al. Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. , 2012, Journal of abnormal psychology.
[112] J. Rossi,et al. Double-Blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in College Students With ADHD , 2012, Journal of attention disorders.
[113] I. Sigfusdottir,et al. An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. , 2012, Journal of child psychology and psychiatry, and allied disciplines.
[114] Karenleigh A. Overmann,et al. Prevalence of ADHD and its subtypes in male and female adult prison inmates. , 2012, Behavioral sciences & the law.
[115] W. Bilker,et al. Methylphenidate and risk of serious cardiovascular events in adults. , 2012, The American journal of psychiatry.
[116] R. Barkley,et al. Lifespan persistence of ADHD: the life transition model and its application. , 2012, The Journal of clinical psychiatry.
[117] Bruce H Fireman,et al. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. , 2011, JAMA.
[118] R. Tremblay,et al. Childhood trajectories of inattention and hyperactivity and prediction of educational attainment in early adulthood: a 16-year longitudinal population-based study. , 2011, The American journal of psychiatry.
[119] R. Kesner,et al. An analysis of rat prefrontal cortex in mediating executive function , 2011, Neurobiology of Learning and Memory.
[120] L. Kiemeney,et al. DIRAS2 is Associated with Adult ADHD, Related Traits, and Co-Morbid Disorders , 2011, Neuropsychopharmacology.
[121] P. Lichtenstein,et al. Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology. , 2011, Journal of child psychology and psychiatry, and allied disciplines.
[122] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[123] A. Arnsten,et al. Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders , 2011, Pharmacology Biochemistry and Behavior.
[124] S. Segal,et al. Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD , 2011, Pediatrics.
[125] S. Faraone,et al. Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: a family risk analysis. , 2011, The American journal of psychiatry.
[126] Fassnacht,et al. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree , 2011, Molecular Psychiatry.
[127] H. Jeon,et al. Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: Results of the Korean epidemiologic catchment area study , 2011, Psychiatry Research.
[128] D. Huse,et al. Risk of injury associated with attention-deficit/hyperactivity disorder in adults enrolled in employer-sponsored health plans: a retrospective analysis. , 2011, The primary care companion for CNS disorders.
[129] T. Hirvikoski,et al. Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. , 2011, Behaviour research and therapy.
[130] S. Segal,et al. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. , 2011, Journal of the American Academy of Child and Adolescent Psychiatry.
[131] David Rigau,et al. Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder , 2011, CNS drugs.
[132] R. Barkley,et al. The Nature of Executive Function (EF) Deficits in Daily Life Activities in Adults with ADHD and Their Relationship to Performance on EF Tests , 2011 .
[133] C. Freitag,et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. , 2010, Molecular psychiatry.
[134] M. Tehrani-Doost,et al. Efficacy of reboxetine in adults with attention‐deficit/hyperactivity disorder: A randomized, placebo‐controlled clinical trial , 2010, Human psychopharmacology.
[135] R. Kessler,et al. Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale. , 2010, Archives of general psychiatry.
[136] Michael Fitzgerald,et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD , 2010, BMC psychiatry.
[137] R. Barkley. Why Emotional Impulsiveness Should Be a Central Feature of ADHD , 2010 .
[138] J. Hebebrand,et al. German Validation of the Conners Adult ADHD Rating Scales–self-report (CAARS-S) I: Factor Structure and Normative Data , 2010, European Psychiatry.
[139] P. Chokka,et al. Adult ADHD and its comorbidities, with a focus on bipolar disorder. , 2010, Journal of affective disorders.
[140] T. Wigal,et al. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design , 2010, Behavioral and Brain Functions.
[141] S. Faraone,et al. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. , 2010, The Journal of clinical psychiatry.
[142] G. Willemsen,et al. Genetic Epidemiology of Attention Deficit Hyperactivity Disorder (ADHD Index) in Adults , 2010, PloS one.
[143] S. Faraone,et al. Molecular genetics of attention deficit hyperactivity disorder. , 2010, The Psychiatric clinics of North America.
[144] J. Norvilitis,et al. ADHD Symptomatology and Its Relationship to Factors Associated With College Adjustment , 2009, Journal of attention disorders.
[145] A. Palmini,et al. Attention deficit hyperactivity disorder and the behavior of “Che” Guevara , 2009, Journal of Clinical Neuroscience.
[146] F Curtis Breslin,et al. Work injury risk among young people with learning disabilities and attention-deficit/hyperactivity disorder in Canada. , 2009, American journal of public health.
[147] L. Weyandt,et al. College Students With ADHD , 2009, Journal of attention disorders.
[148] Jung-Woo Son,et al. Standardization of the Comprehensive Attention Test for the Korean Children and Adolescents. , 2009 .
[149] Benjamin M. Neale,et al. Genome-wide association studies in ADHD , 2009, Human Genetics.
[150] C. Gillberg,et al. Occupational Outcome in Adult ADHD: Impact of Symptom Profile, Comorbid Psychiatric Problems, and Treatment , 2009, Journal of attention disorders.
[151] William Kronenberger,et al. Atomoxetine treatment in adults with attention‐deficit/hyperactivity disorder and comorbid social anxiety disorder , 2009, Depression and anxiety.
[152] S. Bálint,et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis , 2009, British Journal of Psychiatry.
[153] C. Kratochvil,et al. Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder , 2009 .
[154] D. Kang,et al. Shorter dinucleotide repeat length in the DRD5 gene is associated with attention deficit hyperactivity disorder. , 2009, Psychiatric genetics.
[155] B. Johansson,et al. Old people reporting childhood AD/HD symptoms: Retrospectively self-rated AD/HD symptoms in a population-based Swedish sample aged 65–80 , 2009, Nordic journal of psychiatry.
[156] Aribert Rothenberger,et al. Genome‐wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[157] B. Franke,et al. Meta‐analysis of genome‐wide linkage scans of attention deficit hyperactivity disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[158] M. Daly,et al. Genome‐wide association scan of the time to onset of attention deficit hyperactivity disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[159] M. Fitzgerald. Adult deficit hyperactivity disorder and other diagnosis , 2008, Irish Journal of Psychological Medicine.
[160] R. Barkley,et al. Unrecognized Attention-Deficit/Hyperactivity Disorder in Adults Presenting with Other Psychiatric Disorders , 2008, CNS Spectrums.
[161] Ann-Christine Ehlis,et al. Reduced lateral prefrontal activation in adult patients with attention-deficit/hyperactivity disorder (ADHD) during a working memory task: a functional near-infrared spectroscopy (fNIRS) study. , 2008, Journal of psychiatric research.
[162] R. Klein,et al. Lifetime criminality among boys with attention deficit hyperactivity disorder: A prospective follow-up study into adulthood using official arrest records , 2008, Psychiatry Research.
[163] J. Biederman,et al. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. , 2008, The Journal of clinical psychiatry.
[164] J Ormel,et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative , 2008, Occupational and Environmental Medicine.
[165] J. Buitelaar,et al. A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder , 2008, Biological Psychiatry.
[166] R. Plomin,et al. Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. , 2008, Journal of child psychology and psychiatry, and allied disciplines.
[167] L. Hechtman,et al. Research Forum on Psychological Treatment of Adults With ADHD , 2008, Journal of attention disorders.
[168] B. Biswal,et al. Cingulate-Precuneus Interactions: A New Locus of Dysfunction in Adult Attention-Deficit/Hyperactivity Disorder , 2008, Biological Psychiatry.
[169] W. Pelham,et al. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.
[170] N. Laird,et al. Family‐based association analysis of a statistically derived quantitative traits for ADHD reveal an association in DRD4 with inattentive symptoms in ADHD individuals , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[171] Alan C. Evans,et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation , 2007, Proceedings of the National Academy of Sciences.
[172] C. McDougle,et al. Guanfacine and guanfacine extended release: treatment for ADHD and related disorders. , 2007, CNS drug reviews.
[173] S. Rauch,et al. Further Evidence of Dopamine Transporter Dysregulation in ADHD: A Controlled PET Imaging Study Using Altropane , 2007, Biological Psychiatry.
[174] Shuhong Zhao,et al. Candidate Gene Identification Approach: Progress and Challenges , 2007, International journal of biological sciences.
[175] M. Weiss,et al. Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults , 2007, Current psychiatry reports.
[176] T. Spencer,et al. Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. , 2007, Journal of child and adolescent psychopharmacology.
[177] B. Pennington,et al. Understanding comorbidity: A twin study of reading disability and attention‐deficit/hyperactivity disorder , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[178] E. Grevet,et al. Serotonin transporter gene polymorphism and the phenotypic heterogeneity of adult ADHD , 2007, Journal of Neural Transmission.
[179] L. Rohde,et al. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan , 2007, Current opinion in psychiatry.
[180] W. Canu,et al. Rejection Sensitivity and Social Outcomes of Young Adult Men With ADHD , 2007, Journal of attention disorders.
[181] Marley W. Watkins,et al. ADHD and Achievement , 2007, Journal of learning disabilities.
[182] A. Rostain,et al. Issues in ADHD in Adults , 2006 .
[183] P. Herzberg,et al. Diagnostic instruments , 2006, Psycho-social medicine.
[184] B. Molina,et al. Childhood ADHD Predicts Risky Sexual Behavior in Young Adulthood , 2006, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.
[185] E. Sobanski. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD) , 2006, European Archives of Psychiatry and Clinical Neuroscience.
[186] J. Buitelaar,et al. Long-acting medications for the hyperkinetic disorders , 2006, European Child & Adolescent Psychiatry.
[187] L. Hechtman,et al. A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults. , 2006, The Journal of clinical psychiatry.
[188] R. Kessler,et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. , 2006, The American journal of psychiatry.
[189] R. Barkley,et al. Young adult outcome of hyperactive children: adaptive functioning in major life activities. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.
[190] S. Sandberg. the biopsychosocial context of adhd , 2005 .
[191] Joseph Biederman,et al. Attention-Deficit/Hyperactivity Disorder: A Selective Overview , 2005, Biological Psychiatry.
[192] G. Bush,et al. Functional Neuroimaging of Attention-Deficit/Hyperactivity Disorder: A Review and Suggested Future Directions , 2005, Biological Psychiatry.
[193] V. Russell,et al. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. , 2005, The Behavioral and brain sciences.
[194] Joseph Biederman,et al. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies , 2005, Psychological Medicine.
[195] J. Wasserstein,et al. Diagnostic issues for adolescents and adults with ADHD. , 2005, Journal of clinical psychology.
[196] Olga V. Demler,et al. The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population , 2005, Psychological Medicine.
[197] V. Harpin,et al. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life , 2005, Archives of Disease in Childhood.
[198] H. Birnbaum,et al. Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. , 2004, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[199] L. Hechtman,et al. The marital and family functioning of adults with ADHD and their spouses , 2004, Journal of attention disorders.
[200] J. Buitelaar,et al. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial , 2004, Psychological Medicine.
[201] L. Adler,et al. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. , 2004, The Psychiatric clinics of North America.
[202] S. Young. The YAQ-S and YAQ-I: the development of self and informant questionnaires reporting on current adult ADHD symptomatology, comorbid and associated problems , 2004 .
[203] L. Adler. Clinical presentations of adult patients with ADHD. , 2004, The Journal of clinical psychiatry.
[204] Simon E Fisher,et al. Familial and genetic effects on motor coordination, laterality, and reading-related cognition. , 2003, The American journal of psychiatry.
[205] P. Hazell,et al. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.
[206] L. Hechtman,et al. The psychosocial functioning of children and spouses of adults with ADHD. , 2003, Journal of child psychology and psychiatry, and allied disciplines.
[207] K. Macey. Conners' Adult ADHD Rating Scales (CAARS). , 2003 .
[208] R. Bakeman,et al. Concordance of self- and informant ratings of adults' current and childhood attention-deficit/hyperactivity disorder symptoms. , 2002, Psychological assessment.
[209] A. Robin,et al. The Impact of ADHD on Marriage , 2002 .
[210] M. Monuteaux,et al. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid? , 2000, Journal of consulting and clinical psychology.
[211] R. Schachar,et al. Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. , 2000, The American journal of psychiatry.
[212] S. Faraone,et al. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. , 2000, The American journal of psychiatry.
[213] I. Waldman,et al. Sex differences in genetic and environmental influences on DSM-III-R attention-deficit/hyperactivity disorder. , 1999, Journal of abnormal psychology.
[214] S. Faraone,et al. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.
[215] E. Rossini,et al. Retrospective Self-Reported Symptoms of Attention-Deficit Hyperactivity Disorder: Reliability of the Wender Utah Rating Scale , 1995, Psychological reports.
[216] S. Faraone,et al. Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. , 1995, The American journal of psychiatry.
[217] S. Faraone,et al. High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. , 1995, The American journal of psychiatry.
[218] R. Barkley,et al. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment , 1994 .
[219] Judith M. Rumsey,et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. , 1990 .
[220] A. Deister,et al. [Attention-deficit/hyperactivity disorder (ADHD) in adult psychiatry: Data on 12-month prevalence, risk factors and comorbidity]. , 2019, Fortschritte der Neurologie-Psychiatrie.
[221] L. Notardonato,et al. ["Attention deficit hyperactivity disorder in forensic psychiatry: A review"]. , 2017, L'Encephale.
[222] S. Akhondzadeh,et al. Bupropion in adults with Attention-Deficit/Hyperactivity Disorder: a randomized, double-blind study. , 2014, Acta medica Iranica.
[223] F. Petermann,et al. [Adult ADHD versus borderline personality disorder: criteria for differential diagnosis]. , 2014, Fortschritte der Neurologie-Psychiatrie.
[224] T. Epstein,et al. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. , 2014, The Cochrane database of systematic reviews.
[225] G. Willemsen,et al. Genetic and environmental stability in attention problems across the lifespan: evidence from the Netherlands twin register. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.
[226] Richard E. Tremblay,et al. KmL3D: A non-parametric algorithm for clustering joint trajectories , 2013, Comput. Methods Programs Biomed..
[227] J. Martínez-Raga,et al. Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder , 2012, CNS Drugs.
[228] Tova Rosenbloom,et al. Thirty-day self-reported risky driving behaviors of ADHD and non-ADHD drivers. , 2011, Accident; analysis and prevention.
[229] J. Naglieri,et al. Encyclopedia of child behavior and development , 2011 .
[230] A. Philipsen,et al. KAPITEL 7 – Coaching , 2008 .
[231] D. Cox,et al. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. , 2007, Journal of safety research.
[232] M. Willoughby. Developmental course of ADHD symptomatology during the transition from childhood to adolescence: a review with recommendations. , 2003, Journal of child psychology and psychiatry, and allied disciplines.
[233] J. Biederman,et al. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. , 2000, Journal of child and adolescent psychopharmacology.
[234] T. Brown. Attention-deficit disorders and comorbidities in children, adolescents, and adults , 2000 .
[235] Kevin R. Murphy,et al. Attention-deficit hyperactivity disorder: A clinical workbook, 2nd ed. , 1998 .
[236] Kevin R. Murphy,et al. Attention-deficit hyperactivity disorder : a clinical workbook , 1991 .